About Recursion Pharmaceuticals Inc - Ordinary Shares - Class A - Company Information, Overview, History and Profile

What does Recursion Pharmaceuticals Inc - Ordinary Shares - Class A do?

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.

Recursion Pharmaceuticals Inc - Ordinary Shares - Class A Management structure

All Gross Remunerations are in USD

Dr. Shafique Virani, M.D.

Chief Corporate Development Officer

-

2024

Gross Remuneration

Year

Mr. Matthew Kinn

Chief Business Officer

-

2024

Gross Remuneration

Year

Dr. Najat Khan, PhD

Director, Chief Research and Development Officer and Chief Commercial Officer

-

2024

Gross Remuneration

Year

Mr. Ben R. Taylor

Chief Financial Officer, Principal Accounting Officer and President, Recursion UK

-

2024

Gross Remuneration

Year

Dr. Christopher Gibson, PhD

Chief Executive Officer, Director and President

-

2024

Gross Remuneration

Year

Ms. Tina Marriott Larson

President and Chief Operating Officer

-

2024

Gross Remuneration

Year

Recursion Pharmaceuticals Inc - Ordinary Shares - Class A Board of directors

All Gross Remunerations are in USD

Ms. Elaine D. Sun

Director

-

2025

Gross Remuneration

Year

Dr. Namandje N. Bumpus, PhD

Director

-

2025

Gross Remuneration

Year